Eric S Christenson

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Patients Undergoing

Neoadjuvant Chemotherapy

Top Venues

Cancer research communications

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Stephanie L Alden, Valerie Lee, Amol K Narang, Jeffrey Meyer, Susan L Gearhart, Eric S Christenson
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer. The oncologist 29 (3) (2024)
Stephanie L Alden, Valerie Lee, Amol K Narang, Jeffrey Meyer, Susan L Gearhart, Eric S Christenson
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer. The oncologist (2024)
Eric S Christenson, Su Jin Lim, Jennifer N Durham, Ana M C De Jesus-Acosta, Katherine M Bever, Daniel A Laheru, Amy Ryan, Parul Agarwal, Robert B Scharpf, Dung T Le, Hao Wang
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer research communications 2 (11) (2022)
Eric S Christenson, Jeffrey Meyer
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer? Current oncology reports 24 (11) (2022)
Eric S Christenson, Su Jin Lim, Jennifer N Durham, Ana M C De Jesus-Acosta, Katherine M Bever, Daniel A Laheru, Amy Ryan, Parul Agarwal, Robert B Scharpf, Dung T Le, Hao Wang
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer research communications 2 (11) (2022)